BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 10741131)

  • 1. [Clinical staging classification of non-Hodgkin's lymphoma].
    Izumi T; Ozawa K
    Nihon Rinsho; 2000 Mar; 58(3):598-601. PubMed ID: 10741131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Staging classification of malignant lymphoma].
    Takagi T
    Gan To Kagaku Ryoho; 1998 Aug; 25(10):1619-22. PubMed ID: 9725059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Staging of non-Hodgkin's lymphoma--recommendations of the Czech Lymphoma Study Group].
    Sýkorová A; Belada D; Smolej L; Pytlík R; Benesová K; Vásová I; Papajík T; Sálek D; Procházka V; Matuska M; Brejcha M; Kubácková K; Kabícková E; Móciková H; Campr V; Trnený M;
    Klin Onkol; 2010; 23(3):146-54. PubMed ID: 20608324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognostic significance of the histological classification and staging for patients with a malignant non-Hodgkin lymphoma].
    Raemaekers JM; Snoeijen JJ; Bogman MJ; Rutten E; Strijk SP; Manni JJ
    Ned Tijdschr Geneeskd; 1993 Apr; 137(16):815-20. PubMed ID: 8487885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognostic factors in patients with primary non-Hodgkin's lymphoma of the tonsil].
    Gao Y; Li Y; Yuan Z; Zhao L; Liu X; Gu D; Qian T; Yu Z
    Zhonghua Zhong Liu Za Zhi; 2002 Sep; 24(5):483-5. PubMed ID: 12485504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases].
    Yao B; Li YX; Fang H; Jin J; Liu XF; Yu ZH
    Ai Zheng; 2006 Apr; 25(4):465-70. PubMed ID: 16613682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunophenotype, histopathology and clinical stage: their predictive value in the prognosis of non-Hodgkin's lymphomas.
    Mtasiwa DM; Imamura N; Inada T; Takimoto Y; Okada K; Nanba K; Asaoku H; Kuramoto A
    Hiroshima J Med Sci; 1990 Dec; 39(4):95-102. PubMed ID: 2086567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical features, treatment and prognosis of 136 patients with primary non-Hodgkin's lymphoma of the nasopharynx].
    Yuan ZY; Li YX; Zhao LJ; Gao YH; Liu XF; Gu DZ; Qian TN; Yu ZH
    Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):425-9. PubMed ID: 15355649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical studies on eleven patients with nasal and paranasal lymphoma, with special reference to staging evaluation].
    Shimizu K; Hara K; Ohnishi K; Kunii A
    Rinsho Ketsueki; 1989 Feb; 30(2):181-4. PubMed ID: 2746874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical features of 89 patients with primary non-Hodgkin's lymphoma of the tonsil].
    Qin Y; Shi YK; He XH; Yang JL; Yang S; Yu YX; Li B; Wang QL; Zhou LQ; Sun Y
    Ai Zheng; 2006 Apr; 25(4):481-5. PubMed ID: 16613685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hodgkin's and non-Hodgkin's lymphoma of the head and neck.
    Urquhart A; Berg R
    Laryngoscope; 2001 Sep; 111(9):1565-9. PubMed ID: 11568605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lymphoid depletion type 4 Hodgkin disease. Anatomoclinical review of 35 cases].
    Eghbali H; Pétorin C; de Mascarel I; Trojani M; Hoerni-Simon G; Soubeyran P; Hoerni B
    Bull Cancer; 1994 Oct; 81(10):866-70. PubMed ID: 7734769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin's lymphoma differ by non-Hodgkin's lymphoma subtype: a Berlin-Frankfurt-Munster Group Report.
    Salzburg J; Burkhardt B; Zimmermann M; Wachowski O; Woessmann W; Oschlies I; Klapper W; Wacker HH; Ludwig WD; Niggli F; Mann G; Gadner H; Riehm H; Schrappe M; Reiter A
    J Clin Oncol; 2007 Sep; 25(25):3915-22. PubMed ID: 17761975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applicability of international prognostic index in non Hodgkin's lymphoma in Pakistan.
    Aziz Z; Sana S; Saeed S; Akram M
    J Ayub Med Coll Abbottabad; 2004; 16(2):15-20. PubMed ID: 15455610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Non-Hodgkin's lymphoma: morphologic, immunologic and cytogenetic classification].
    Ristić S; Jovanović V; Ristić S; Radojković M
    Srp Arh Celok Lek; 1996; 124(9-10):276-82. PubMed ID: 9102863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localized B-cell non-Hodgkin's lymphoma of oral cavity and maxillofacial region: a clinical study.
    Kolokotronis A; Konstantinou N; Christakis I; Papadimitriou P; Matiakis A; Zaraboukas T; Antoniades D
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Mar; 99(3):303-10. PubMed ID: 15716836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ki-67 proliferative index in non-Hodgkin's lymphoma and its clinical significance].
    Li J; Hu R; Liao AJ; Shi HY; Yan W; Liu ZG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):935-9. PubMed ID: 21867618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Primary gastric non-Hodgkin's lymphoma: clinical findings and prognostic factors].
    Guzicka-Kazimierczak R
    Ann Acad Med Stetin; 2006; 52(3):77-84; discussion 84. PubMed ID: 17385352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Malignant lymphoma: a study of an outpatient cohort].
    Burla M; Egli F; Rhyner K
    Schweiz Rundsch Med Prax; 1990 Jan; 79(5):101-10. PubMed ID: 2305142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum CA 125 is of clinical value in the staging and follow-up of patients with non-Hodgkin's lymphoma: correlation with tumor parameters and disease activity.
    Lazzarino M; Orlandi E; Klersy C; Astori C; Brusamolino E; Corso A; Bellio L; Gargantini L; Morra E; Bernasconi C
    Cancer; 1998 Feb; 82(3):576-82. PubMed ID: 9452277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.